Winner of Elon Musk’s XPRIZE 2021
Winner of Shell New Energy Challenge 2023
Winner of L'Oreal GSI 2024
Winner of Horizon Europe 2024
About
Breakthrough synthetic biology.
Resilient biomanufacturing.
Platform technology for producing hard-to-synthesise molecules from enzymes to drug precursors in short supply.
METRICS
$40 bn
Total market size of products synthesised at cost parity or less
200+
GMO strains engineered
3/7
Biological products in the pipeline successfully synthesised from platform
2
Private contracts delivered
$27m
Pre-orders & LOIs
De-risking critical supply chains
Better than Alchemy.
Turning CO2 into Interferon-alpha. Biology performs a biochemical transformation that is more significant than turning straw into gold.
Step 1
The 'Rolls-Royce engine' of biology
A patented record-breaking genetically engineered cell. Robust. Scalable. Doubles every 2.2 hours. Does not need sugars or FBS. This is the chassis on which all our production is built.
Step 2
Deciphering 3 million base pairs of DNA code
We turn the chassis into a powerful molecular factory - secreting valuable molecules synthesised from absorbed CO2.
Two years of intense development produced patented cloning methods, CRISPR and a proprietary library of genetic parts and unique methods. CyanoCapture has quietly engineered 200+ strains with unparalleled degrees of freedom.
Step 3
Self-reliant plug-and-play systems
These cells are loaded into low-cost vessels and pumped with CO2 and exposed to outdoor or artificial illumination. Cells self-replicate and self-repair its biomachinery.
Step 4
Unparalleled manufacturing efficiency
$40+ billion worth of high-value compounds can be synthesised at radically low cost by eliminating expensive ingredients.
How it works
Our Core Technology
Proprietary multi-omics datasets to gain unparalleled genetic control of the world's original photosynthetic machine.
Industrial Enzymes
Peptides
Commodity chemicals
Bioplastics
Growth factors
Cytokines
Serum-free media
Targeted drug delivery (Protein shell nanocages)
A Swiss Army knife for biomanufacturing. Getting the world ready for the explosion in AI-discovered molecules.
Case Study
A $30bn market drug molecule - breakthrough
Though this drug is currently manufactured already by genetically engineered microbes, so far no one has been able to power this process without using chemical energy inputs. We are the first company globally to successfully synthesise this molecule using a zero-sugar process.
Working at scale.
New website launching soon
